Cesarean Section Pain Clinical Trial
Official title:
Bupivacaine Versus Meloxicam Infiltration on Post Cesarean Section Pain Relief
Investigation: compare the effect of local infiltration of incision site with bupivacaine and
local infiltration with meloxicam in women undergoing cesarean sections on postoperative pain
relief and analgesic requirement.
Condition: post cesarean sections analgesia intervention: infiltration of incision
bupivacaine versus meloxicam Phase: Not applicable
study type: randomized clinical trial actual enrollment: 119 allocation: Random intervention model: three groups assignment masking: open lebal primary purpose: pain relief after Cesarean section actual study start: March 3, 2019 Primary Completion: March 5, 2020 actual study completion date: May 9, 2020 ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05276206 -
Application of Transversus Abdominus Plain Block, Local Subcutaneous Injection and IV Nalbuphine
|
Phase 1 | |
Completed |
NCT03918187 -
Intrathecal Nalbuphine Versus Midazolam in Cesarean Section
|
Phase 1 |